Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Alnylam Pharmaceuticals, Marina Biotech, and More


Title: Methods and Means for Producing Efficient Silencing Construct Using Recombinatorial Cloning

Patent Number: 8,877,435

Filed: Sept. 21, 2010

Lead Inventor: Christopher Helliwell, Commonwealth Scientific and Industrial Research Organization

Title: Method for Rapidly Evaluating Performance of Short Interfering RNA with Novel Chemical Modifications

Patent Number: 8,877,439

Filed: Dec. 9, 2010

Lead Inventor: Gabor Butora, Sirna Therapeutics (Alnylam Pharmaceuticals)

Title: Compositions for Inhibiting Gene Expression and Uses Thereof

Patent Number: 8,877,722

Filed: March 25, 2011

Lead Inventor: Sudhir Agrawal, Idera Pharmaceuticals

Title: Method and Medicament for Inhibiting the Expression of a Given Gene

Patent Number: 8,877,726

Filed: Oct. 19, 2012

Lead Inventor: Roland Kreutzer, Alnylam Pharmaceuticals

Title: Delivery of dsRNA to Arthropods

Patent Number: 8,877,727

Filed: April 5, 2013

Lead Inventor: Steven Whyard, Commonwealth Scientific and Industrial Research Organization

Title: Amino Acid Lipids and Uses Thereof

Patent Number: 8,877,729

Filed: July 1, 2013

Lead Inventor: Steven Quay, Marina Biotech

Title: Glycoconjugates of RNA Interference Agents

Patent Number: 8,877,917

Filed: April 23, 2008

Lead Inventor: Andrea Forst, Alnylam Pharmaceuticals